Please join us for this Webinar and learn about the following:

• Why did the Trump Administration launch this measure
• How will this look in practice?
• What are the expected consequences for Medicines Access in the EU and Belgium in particular? 

We are excited to present the following speakers on this topic:

• Justin McCarthy, DGA – Washington Office
• Prof. Walter Van Dyck, VBS Vlerick Business School (panel debate)
• Karel Joos, DGA – Brussels Office (panel debate)

The session will be moderated by Marjan Willaert and Sven Tops from the Healixia Market Access Education Group.